Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 4.4B | 4.0B | 2.3B | 6.1B |
Cost of revenue | 2.3B | 2.5B | 1.6B | 2.9B |
Gross profit | 2.1B | 1.5B | 761M | 3.2B |
Operating expense | ||||
Research & development | 335M | 365M | 348M | 357M |
Selling general and admin | 751M | 626M | 708M | 1.1B |
Other operating expenses | — | — | — | — |
Operating income | 827M | 327M | -465M | 1.6B |
Non operating interest income | ||||
Income | 32M | 39M | 33M | 25M |
Expense | 36M | 60M | 66M | 66M |
Other income expense | -39M | -218M | -135M | -194M |
Pretax income | 784M | 88M | -633M | 1.3B |
Tax provision | 117M | 138M | -114M | 282M |
Net income | 656M | -39M | -521M | 1.1B |
Basic EPS | 1.0 | -0.1 | -0.8 | 1.5 |
Diluted EPS | 1.0 | -0.1 | -0.8 | 1.5 |
Basic average shares | 684.9M | 687.3M | 691.1M | 695.9M |
Diluted average shares | 686.6M | 687.3M | 691.1M | 698.1M |
EBITDA | 1.2B | 589M | -132M | 1.9B |
Net income from continuing op. | 667M | -79M | -505M | 1.1B |
Minority interests | -4M | -2M | -3M | -3M |
Preferred stock dividends | — | — | — | — |